Cargando…

Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview

Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikdar, Nilabja, Saha, Gourab, Dutta, Ashmita, Ghosh, Shibajyoti, Shrikhande, Shailesh V., Banerjee, Sudeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128383/ https://www.ncbi.nlm.nih.gov/pubmed/30258276 http://dx.doi.org/10.2174/1389202919666180221160753

Ejemplares similares

A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients
por: Saha, Gourab, et al.
Publicado: (2020)

DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort
por: Chatterjee, Ankita, et al.
Publicado: (2022)

Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)—basis and current status
por: Ramaswamy, Anant, et al.
Publicado: (2022)

Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways
por: Bararia, Akash, et al.
Publicado: (2023)

An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma
por: Sarnecka, Agnieszka K., et al.
Publicado: (2016)

Pancreatic ascariasis with periampullary carcinoma
por: Arulprakash, S, et al.
Publicado: (2015)

Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers
por: Calatayud, Dan, et al.
Publicado: (2017)

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Improved Results for Resection of Periampullary Adenocarcinoma
por: Obertop, H., et al.
Publicado: (1996)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)

The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
por: Quiñonero, Francisco, et al.
Publicado: (2019)

Genetics and biology of pancreatic ductal adenocarcinoma
por: Ying, Haoqiang, et al.
Publicado: (2016)

Large retroperitoneal paraganglioma concurrent with periampullary adenocarcinoma
por: Hakimian, Seyed Mohammadreza, et al.
Publicado: (2013)

Primary Duodenal Periampullary Adenocarcinoma: An Uncommon Presentation
por: Zackria, Rasiq, et al.
Publicado: (2021)

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma
por: Thosani, Nirav, et al.
Publicado: (2022)

Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head
por: Safi, Sami-Alexander, et al.
Publicado: (2022)

Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
por: Xu, Rui, et al.
Publicado: (2019)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021)

Pancreatoduodenectomy for Periampullary Tumors Presenting with Acute Pancreatitis
por: Cao, Xuefeng, et al.
Publicado: (2020)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
por: Fristedt, Richard, et al.
Publicado: (2014)

Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma
por: Lundgren, Sebastian, et al.
Publicado: (2020)

Periampullary Neuroendocrine Tumor as a Cause of Acute Pancreatitis
por: Nicolas, Gregory, et al.
Publicado: (2018)

Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions
por: Shyr, Yi‐Ming, et al.
Publicado: (2021)

Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
por: Hayashi, Akimasa, et al.
Publicado: (2020)

Comparison of Laparoscopic and Open Pancreaticoduodenectomy for the Treatment of Nonpancreatic Periampullary Adenocarcinomas
por: Meng, Ling-Wei, et al.
Publicado: (2018)

Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
por: Andersson, Gustav, et al.
Publicado: (2019)

Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin
por: Komine, Ryuji, et al.
Publicado: (2021)

Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma
por: Mori, Taiki, et al.
Publicado: (2018)

Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment
por: Sebastian, Aimy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovrgo07detu1rjbaq73q0hhv9r